|
WO2019020734A1
|
|
Anti-bag3 antibodies as therapeutic reagent in cardiovascular diseases
|
|
IT201700113648A1
|
|
Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases
|
|
IT201600111877A1
|
|
Anti-BAG3 antibodies in combination with inhibitors of immune check-point for therapeutic use
|
|
ITUB20155097A1
|
|
Humanized anti-BAG3 antibodies
|
|
KR20160037951A
|
|
Bag3 receptor binding molecules for use as a medicament
|
|
ITMI20130403A1
|
|
ANTI-BAG3 ANTIBODIES FOR THERAPEUTIC USE
|
|
EP2676966A1
|
|
BAG3 as biochemical serum and tissue marker
|
|
ITMI20092154A1
|
|
SERIOUS BIOCHEMICAL MARKER
|
|
EP1465927A2
|
|
Bag3 antibodies to be used in research, diagnostics and therapy for cell death-involving diseases
|
